| abstract |
Pharmaceutical compositions are disclosed. They are useful for the treatment of medical conditions associated with the effects of glutamate, comprise as active principle, at least one compound of formula: <IMAGE> (I) or a salt thereof, in which either R1 represents polyfluoroalkoxy, 2,2,2-trifluoroethyl, pentafluoroethyl, tert-butyl, trimethylsilyl or trifluoromethylthio and R2 and R3 represent hydrogen, or R1 represents polyfluoroalkoxy, R2 represents hydrogen and R3 represents alkyl, amino, alkoxy, phenyl, phenylalkyl, dimethylamino or dialkylaminoakylthio, or R1 represents polyfluoroalkoxy, R2 represents amino and R3 represents hydrogen, with the exception of 6-trifluoromethoxy-2-benzothiazolamine. |